The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets
Abstract
For the past century, insulin injections have saved millions of lives, but glycemic instability is still a persistent challenge for people with diabetes, leading to tremendous morbidity and premature mortality. Research in the field of islet transplantation has demonstrated that replacing insulin-producing β cells can restore euglycemia comparable to individuals without diabetes. However, a short supply of cadaveric islet donors, the technically challenging process of isolating islets, and the requirement for chronic immune suppression have impeded widespread clinical adoption. Rather than relying on cadaveric cells, pluripotent stem cells could serve as a virtually unlimited supply of insulin-producing β cells. Protocols have been developed that mimic the normal in vivo development of the human pancreas to generate pancreatic progenitor cells in vitro. Ongoing investigations have yielded progressively more mature β-like cells in vitro that produce insulin but do not yet fully mimic healthy mature β cells. Alongside development of differentiation protocols, other work has provided insight into potential implantation sites for stem cell–derived islet cells including the subcutaneous space, portal vein, and omentum. To optimize implanted cell survival and function, development of immune modulation therapies is ongoing, including selection of immunomodulatory medications and genetic modification of implanted cells to evade immune responses. Further, macroencapsulation or microencapsulation devices could be used to contain and/or immunoprotect implanted cells from the immune response including by using 3-dimensional bioprinting to facilitate the process. Remarkably, ongoing clinical trials have now yielded the first patient relying on differentiated stem cells rather than syringes as their insulin replacement therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Human islets derived from stem cells (SC) hold immense promise for the transformation of care for people living with diabetes1–3.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025
International trial of the Edmonton protocol for islet transplantation
Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segrè, A. V., Steinthorsdottir, V., Strawbridge, R. J., Khan, H., Grallert, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2383 · Cited by 1,912
Five-Year Follow-Up After Clinical Islet Transplantation
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R. T., & Shapiro, A. M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2060 · Cited by 1,641
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Self-citationInducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Di Stasi, A., Tey, S.-K., Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof, K., Liu, E., Durett, A. G., Grilley, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106152 · Cited by 1,512
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Research works printed but not linked: 317
- International Diabetes Foundation, 2021, IDF Diabetes Atlas
- Aleksandrovski, 1998, Molecular mechanisms of diabetic complications, Biochemistry (Mosc)., 63, 1249
- Olehnik, 2017, Quantitative analysis of intra- and inter-individual variability of human beta-cell mass, Sci Rep, 7, 16398, 10.1038/s41598-017-16300-w · DOI
- Ionescu-Tirgoviste, 2015, A 3D map of the islet routes throughout the healthy human pancreas, Sci Rep, 5, 14634, 10.1038/srep14634 · DOI · Paper page
- Schuit, 1991, Measuring the balance between insulin synthesis and insulin release, Biochem Biophys Res Commun, 178, 1182, 10.1016/0006-291X(91)91017-7 · DOI
- Liu, 2018, Biosynthesis, structure, and folding of the insulin precursor protein, Diabetes Obes Metab, 20, 28, 10.1111/dom.13378 · DOI · Paper page
- Walker, 2021, The human islet: mini-organ with mega-impact, Endocr Rev, 42, 605, 10.1210/endrev/bnab010 · DOI
- Freckmann, 2007, Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals, J Diabetes Sci Technol, 1, 695, 10.1177/193229680700100513 · DOI · Paper page
- Bentsi-Barnes, 2011, Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function, Islets, 3, 284, 10.4161/isl.3.5.15938 · DOI
- Rorsman, 2003, Insulin granule dynamics in pancreatic beta cells, Diabetologia, 46, 1029, 10.1007/s00125-003-1153-1 · DOI · Paper page
- Holst, 2007, The physiology of glucagon-like peptide 1, Physiol Rev, 87, 1409, 10.1152/physrev.00034.2006 · DOI · Paper page
- McIntosh, 2012, Glucose-dependent insulinotropic polypeptide signaling in pancreatic beta-cells and adipocytes, J Diabetes Investig, 3, 96, 10.1111/j.2040-1124.2012.00196.x · DOI
- Schuit, 1985, Regulation of adenosine 3’,5'-monophosphate levels in the pancreatic B cell, Endocrinology, 117, 834, 10.1210/endo-117-3-834 · DOI
- Pipeleers, 1985, Interplay of nutrients and hormones in the regulation of insulin release, Endocrinology, 117, 824, 10.1210/endo-117-3-824 · DOI · Paper page
- Chambers, 2017, The role of pancreatic preproglucagon in glucose homeostasis in mice, Cell Metab, 25, 927, 10.1016/j.cmet.2017.02.008 · DOI · Paper page
- Dai, 2022, Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation state, Cell Metab, 34, 256, 10.1016/j.cmet.2021.12.021 · DOI
- Salehi, 2007, Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon, Regul Pept, 144, 43, 10.1016/j.regpep.2007.06.003 · DOI
- Kailey, 2012, SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells, Am J Physiol Endocrinol Metab, 303, E1107, 10.1152/ajpendo.00207.2012 · DOI · Paper page
- Swayne, 2009, The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line, EMBO Rep, 10, 873, 10.1038/embor.2009.125 · DOI
- Thomas, 2018, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, Lancet Diabetes Endocrinol, 6, 122, 10.1016/S2213-8587(17)30362-5 · DOI · Paper page
- Brown, 2001, All-cause mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population, Diabetes Care, 24, 56, 10.2337/diacare.24.1.56 · DOI
- Mohan, 2011, Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion, J Exp Med, 208, 2375, 10.1084/jem.20111502 · DOI
- Mohan, 2013, Pathogenic CD4+ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes, J Exp Med, 210, 2403, 10.1084/jem.20130582 · DOI
- Carrero, 2017, Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice, Proc Natl Acad Sci U S A, 114, E10418, 10.1073/pnas.1713543114 · DOI · Paper page
- Pugliese, 2017, Autoreactive T cells in type 1 diabetes, J Clin Invest, 127, 2881, 10.1172/JCI94549 · DOI · Paper page
- Wan, 2018, Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides, Nature, 560, 107, 10.1038/s41586-018-0341-6 · DOI
- Jeker, 2012, Breakdown in peripheral tolerance in type 1 diabetes in mice and humans, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a007807 · DOI
- Fan, 2009, Thymus-specific deletion of insulin induces autoimmune diabetes, EMBO J, 28, 2812, 10.1038/emboj.2009.212 · DOI · Paper page
- Soleimanpour, 2013, The pancreatic beta cell and type 1 diabetes: innocent bystander or active participant?, Trends Endocrinol Metab, 24, 324, 10.1016/j.tem.2013.03.005 · DOI
- Norris, 2020, Type 1 diabetes-early life origins and changing epidemiology, Lancet Diabetes Endocrinol, 8, 226, 10.1016/S2213-8587(19)30412-7 · DOI · Paper page
- Lee, 2011, Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion, Proc Natl Acad Sci U S A, 108, 8885, 10.1073/pnas.1105564108 · DOI · Paper page
- Xie, 2002, Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation, Hepatology, 36, 592, 10.1053/jhep.2002.35441 · DOI · Paper page
- Engin, 2013, Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes, Sci Transl Med, 5, 10.1126/scitranslmed.3006534 · DOI · Paper page
- Lee, 2020, Beta cell dedifferentiation induced by IRE1alpha deletion prevents type 1 diabetes, Cell Metab, 31, 822, 10.1016/j.cmet.2020.03.002 · DOI · Paper page
- Ilonen, 2019, The heterogeneous pathogenesis of type 1 diabetes mellitus, Nat Rev Endocrinol, 15, 635, 10.1038/s41574-019-0254-y · DOI · Paper page
- Gujral, 2013, Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations, Ann N Y Acad Sci, 1281, 51, 10.1111/j.1749-6632.2012.06838.x · DOI · Paper page
- Petersen, 2006, Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men, Proc Natl Acad Sci U S A, 103, 18273, 10.1073/pnas.0608537103 · DOI · Paper page
- Voight, 2010, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nat Genet, 42, 579, 10.1038/ng.609 · DOI · Paper page
- Mahajan, 2018, Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes, Nat Genet, 50, 559, 10.1038/s41588-018-0084-1 · DOI · Paper page
- Diabetes Canada Clinical Practice Guidelines Expert Committee, 2018, Pharmacologic glycemic management of type 2 diabetes in adults, Can J Diabetes, 42, S88
- Gruessner, 2016, Pancreas transplantation of US and Non-US cases from 2005 to 2014 as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR), Rev Diabet Stud, 13, 35, 10.1900/RDS.2016.13.35 · DOI · Paper page
- Boland, 2019, Pancreatic β-cell rest replenishes insulin secretory capacity and attenuates diabetes in an extreme model of obese type 2 diabetes, Diabetes, 68, 131, 10.2337/db18-0304 · DOI
- Aguilar-Bryan, 2008, Neonatal diabetes mellitus, Endocr Rev, 29, 265, 10.1210/er.2007-0029 · DOI · Paper page
- Firdous, 2018, Genetic testing of maturity-onset diabetes of the young current status and future perspectives, Front Endocrinol (Lausanne), 17, 253, 10.3389/fendo.2018.00253 · DOI
- McIntyre, 2019, Gestational diabetes mellitus, Nat Rev Dis Primers, 5, 47, 10.1038/s41572-019-0098-8 · DOI · Paper page
- Flier, 2019, Starvation in the midst of plenty: reflections on the history and biology of insulin and leptin, Endocr Rev, 40, 1, 10.1210/er.2018-00179 · DOI
- Karamitsos, 2011, The story of insulin discovery, Diabetes Res Clin Pract, 93, S2, 10.1016/S0168-8227(11)70007-9 · DOI
- Cox, 2011, Elizabeth Evans Hughes—surviving starvation therapy for diabetes, Lancet, 377, 1232, 10.1016/S0140-6736(11)60490-X · doi:10.1016/s0140-6736(11)60490-x
- Russell, 2015, 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications, Diabetologia, 58, 1708, 10.1007/s00125-015-3600-1 · DOI
- Hirsch, 2020, The evolution of insulin and how it informs therapy and treatment choices, Endocr Rev, 41, 733, 10.1210/endrev/bnaa015 · DOI · Paper page
- Goeddel, 1979, Expression in Escherichia coli of chemically synthesized genes for human insulin, Proc Natl Acad Sci U S A, 76, 106, 10.1073/pnas.76.1.106 · DOI · Paper page
- Mathieu, 2017, Insulin analogues in type 1 diabetes mellitus: getting better all the time, Nat Rev Endocrinol, 13, 385, 10.1038/nrendo.2017.39 · DOI · Paper page
- DeVries, 2002, A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control, Diabetes Care, 25, 2074, 10.2337/diacare.25.11.2074 · DOI · Paper page
- Schade, 2002, To pump or not to pump, Diabetes Care, 25, 2100, 10.2337/diacare.25.11.2100 · DOI
- Boughton, 2019, Advances in artificial pancreas systems, Sci Transl Med, 11, 10.1126/scitranslmed.aaw4949 · DOI
- Lewis, 2019, History and perspective on DIY closed looping, J Diabetes Sci Technol, 13, 790, 10.1177/1932296818808307 · DOI
- Kulcu, 2003, Physiological differences between interstitial glucose and blood glucose measured in human subjects, Diabetes Care, 26, 2405, 10.2337/diacare.26.8.2405 · DOI · Paper page
- Ekberg, 2003, Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes, Diabetes, 52, 536, 10.2337/diabetes.52.2.536 · DOI · Paper page
- Schmitz, 2004, Amylin agonists: a novel approach in the treatment of diabetes, Diabetes, 53, S233, 10.2337/diabetes.53.suppl_3.S233 · DOI · Paper page
- Ekberg, 2007, C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy, Diabetes Care, 30, 71, 10.2337/dc06-1274 · DOI · Paper page
- Pullen, 2021, Islet cell transplantation hits a milestone, Am J Transplant, 21, 2625, 10.1111/ajt.16039 · doi:10.1111/ajt.16039
- Kelly, 1967, Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy, Surgery, 61, 827
- Bahar, 2021, Pancreas Transplantation
- Gruessner, 2016, Long-term outcome after pancreas transplantation: a registry analysis, Curr Opin Organ Transplant, 21, 377, 10.1097/MOT.0000000000000331 · DOI
- Gruessner, 2014, Declining numbers of pancreas transplantations but significant improvements in outcome, Transplant Proc, 46, 1936, 10.1016/j.transproceed.2014.06.045 · DOI
- Stratta, 2016, Pancreas transplantation: an alarming crisis in confidence, Am J Transplant, 16, 2556, 10.1111/ajt.13890 · DOI
- Moskalewski, 1965, Isolation and culture of the islets of Langerhans of the guinea pig, Gen Comp Endocrinol, 5, 342, 10.1016/0016-6480(65)90059-6 · DOI · Paper page
- Lacy, 1967, Method for the isolation of intact islets of Langerhans from the rat pancreas, Diabetes, 16, 35, 10.2337/diab.16.1.35 · DOI · Paper page
- Ballinger, 1972, Transplantation of intact pancreatic islets in rats, Surgery, 72, 175
- Lindall, 1969, Immunoassayable insulin content of subcellular fractions of rat islets, Endocrinology, 85, 218, 10.1210/endo-85-2-218 · doi:10.1210/endo-85-2-218
- Horaguchi, 1981, Preparation of viable islet cells from dogs by a new method, Diabetes, 30, 455, 10.2337/diab.30.5.455 · DOI
- Largiadér, 1980, A long term functioning human pancreatic islet allotransplant, Transplantation, 29, 76, 10.1097/00007890-198001000-00017 · DOI
- Ricordi, 1988, Automated method for isolation of human pancreatic islets, Diabetes, 37, 413, 10.2337/diab.37.4.413 · DOI · Paper page
- Piemonti, 2013, 25 years of the Ricordi automated method for islet isolation, CellR4 Repair Replace Regen Reprogram, 1, e128
- Shapiro, 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, N Engl J Med, 343, 230, 10.1056/NEJM200007273430401 · DOI · Paper page
- Shapiro, 2019, Islet transplantation—the Canadian perspective, CellR4 Repair Replace Regen Reprogram, 7, e2799
- Shapiro, 2017, Clinical pancreatic islet transplantation, Nat Rev Endocrinol, 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
- Marfil-Garza, 2022, Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada, Lancet Diabetes Endocrinol, 10, 519, 10.1016/S2213-8587(22)00114-0 · DOI · Paper page
- Foster, 2018, Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia, Diabetes Care, 41, 1001, 10.2337/dc17-1779 · DOI
- Robertson, 2010, Islet transplantation a decade later and strategies for filling a half-full glass, Diabetes, 59, 1285, 10.2337/db09-1846 · DOI
- Zhong, 2019, Endogenous pancreatic β cell regeneration: a potential strategy for the recovery of β cell deficiency in diabetes, Front Endocrinol (Lausanne), 20, 101, 10.3389/fendo.2019.00101 · DOI
- Yang, 2020, A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of beta cells, Sci Adv, 6, eabc3207, 10.1126/sciadv.abc3207 · DOI
- Till, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat Res, 14, 213, 10.2307/3570892 · DOI · Paper page
- Takahashi, 2013, Induced pluripotent stem cells in medicine and biology, Development, 140, 2457, 10.1242/dev.092551 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Kimura-Yoshida, 2005, Canonical Wnt signaling and its antagonist regulate anterior-posterior axis polarization by guiding cell migration in mouse visceral endoderm, Dev Cell, 9, 639, 10.1016/j.devcel.2005.09.011 · DOI · Paper page
- Jorgensen, 2007, An illustrated review of early pancreas development in the mouse, Endocr Rev, 28, 685, 10.1210/er.2007-0016 · DOI · Paper page
- McCracken, 2012, Molecular pathways controlling pancreas induction, Semin Cell Dev Biol, 23, 656, 10.1016/j.semcdb.2012.06.009 · DOI
- Geusz, 2021, Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors, Nat Commun, 12, 6636, 10.1038/s41467-021-26950-0 · DOI
- Jennings, 2013, Development of the human pancreas from foregut to endocrine commitment, Diabetes, 62, 3514, 10.2337/db12-1479 · DOI · Paper page
- Ahlgren, 1996, The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice, Development, 122, 1409, 10.1242/dev.122.5.1409 · DOI · Paper page
- Sander, 2000, Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas, Development, 127, 5533, 10.1242/dev.127.24.5533 · DOI · Paper page
- Schaffer, 2010, Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors, Dev Cell, 18, 1022, 10.1016/j.devcel.2010.05.015 · DOI · Paper page
- Apelqvist, 1999, Notch signalling controls pancreatic cell differentiation, Nature, 400, 877, 10.1038/23716 · DOI · Paper page
- Gradwohl, 2000, Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas, Proc Natl Acad Sci U S A, 97, 1607, 10.1073/pnas.97.4.1607 · DOI · Paper page
- Villasenor, 2008, Biphasic Ngn3 expression in the developing pancreas, Dev Dyn, 237, 3270, 10.1002/dvdy.21740 · DOI
- Johansson, 2007, Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types, Dev Cell, 12, 457, 10.1016/j.devcel.2007.02.010 · DOI · Paper page
- Scavuzzo, 2018, Pancreatic cell fate determination relies on Notch ligand trafficking by NFIA, Cell Rep, 25, 3811, 10.1016/j.celrep.2018.11.078 · DOI
- Krentz, 2018, Single-cell transcriptome profiling of mouse and hESC-derived pancreatic progenitors, Stem Cell Rep, 11, 1551, 10.1016/j.stemcr.2018.11.008 · DOI
- Byrnes, 2018, Lineage dynamics of murine pancreatic development at single-cell resolution, Nat Commun, 9, 3922, 10.1038/s41467-018-06176-3 · DOI · Paper page
- Bastidas-Ponce, 2019, Comprehensive single cell mRNA profiling reveals a detailed roadmap for pancreatic endocrinogenesis, Development, 146, dev173849, 10.1242/dev.173849 · DOI · Paper page
- Salisbury, 2014, The window period of NEUROGENIN3 during human gestation, Islets, 6, e954436, 10.4161/19382014.2014.954436 · DOI
- Nair, 2015, Islet formation in mice and men: lessons for the generation of functional insulin-producing beta-cells from human pluripotent stem cells, Curr Opin Genet Dev, 32, 171, 10.1016/j.gde.2015.03.004 · DOI
- Ahlgren, 1997, Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells, Nature, 385, 257, 10.1038/385257a0 · DOI · Paper page
- Naya, 1997, Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice, Genes Dev, 11, 2323, 10.1101/gad.11.18.2323 · DOI · Paper page
- Collombat, 2005, The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas, Development, 132, 2969, 10.1242/dev.01870 · DOI · Paper page
- Collombat, 2003, Opposing actions of Arx and Pax4 in endocrine pancreas development, Genes Dev, 17, 2591, 10.1101/gad.269003 · DOI · Paper page
- Sussel, 1998, Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells, Development, 125, 2213, 10.1242/dev.125.12.2213 · DOI · Paper page
- Sander, 1997, Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development, Genes Dev, 11, 1662, 10.1101/gad.11.13.1662 · DOI · Paper page
- Ahmad, 2015, Pax6 inactivation in the adult pancreas reveals ghrelin as endocrine cell maturation marker, PLoS One, 10, e0144597, 10.1371/journal.pone.0144597 · DOI
- Gao, 2014, Pdx1 maintains beta cell identity and function by repressing an alpha cell program, Cell Metab, 19, 259, 10.1016/j.cmet.2013.12.002 · DOI · Paper page
- Herrera, 1991, Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene, Development, 113, 1257, 10.1242/dev.113.4.1257 · DOI · Paper page
- Vieira, 2017, β-Cell replacement strategies: the increasing need for a “β-cell dogma.”, Front Genet, 6, 75, 10.3389/fgene.2017.00075 · DOI
- van der Meulen, 2014, Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3, Rev Diabet Stud, 11, 115, 10.1900/RDS.2014.11.115 · DOI
- Xin, 2016, RNA sequencing of single human islet cells reveals type 2 diabetes genes, Cell Metab, 24, 608, 10.1016/j.cmet.2016.08.018 · DOI · Paper page
- Nishimura, 2015, MafA is critical for maintenance of the mature beta cell phenotype in mice, Diabetologia, 58, 566, 10.1007/s00125-014-3464-9 · DOI
- Aguayo-Mazzucato, 2011, Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells, Diabetologia, 54, 583, 10.1007/s00125-010-2026-z · DOI · Paper page
- Shrestha, 2021, Combinatorial transcription factor profiles predict mature and functional human islet α and β cells, JCI Insight, 6, e151621, 10.1172/jci.insight.151621 · DOI
- Bevacqua, 2021, SIX2 and SIX3 coordinately regulate functional maturity and fate of human pancreatic beta cells, Genes Dev, 35, 234, 10.1101/gad.342378.120 · DOI
- Romer, 2019, Murine perinatal β-cell proliferation and the differentiation of human stem cell-derived insulin-expressing cells require NEUROD1, Diabetes, 68, 2259, 10.2337/db19-0117 · DOI
- Yu, 2021, Sequential progenitor states mark the generation of pancreatic endocrine lineages in mice and humans, Cell Res, 31, 886, 10.1038/s41422-021-00486-w · DOI
- Yu, 2019, Defining multistep cell fate decision pathways during pancreatic development at single-cell resolution, EMBO J, 38, 10.15252/embj.2018100164 · DOI
- van Gurp, 2022, Generation of human islet cell type-specific identity genesets, Nat Commun, 13, 2020, 10.1038/s41467-022-29588-8 · DOI
- Muraro, 2016, A single-cell transcriptome atlas of the human pancreas, Cell Syst, 3, 385, 10.1016/j.cels.2016.09.002 · DOI · Paper page
- Qadir, 2020, Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche, Proc Natl Acad Sci U S A, 117, 10876, 10.1073/pnas.1918314117 · DOI · Paper page
- Assady, 2001, Insulin production by human embryonic stem cells, Diabetes, 50, 1691, 10.2337/diabetes.50.8.1691 · DOI · Paper page
- Rajagopal, 2003, Insulin staining of ES cell progeny from insulin uptake, Science, 299, 363, 10.1126/science.1077838 · DOI · Paper page
- Allegrucci, 2007, Differences between human embryonic stem cell lines, Hum Reprod Update, 13, 103, 10.1093/humupd/dml041 · DOI · Paper page
- Segev, 2004, Differentiation of human embryonic stem cells into insulin-producing clusters, Stem Cells, 22, 265, 10.1634/stemcells.22-3-265 · DOI · Paper page
- D’Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat Biotechnol, 23, 1534, 10.1038/nbt1163 · DOI · Paper page
- Ka, 2006, Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells, Nat Biotechnol, 24, 1392, 10.1038/nbt1259 · DOI · Paper page
- Riedel, 2012, Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas, Diabetologia, 55, 372, 10.1007/s00125-011-2344-9 · DOI · Paper page
- Nostro, 2011, Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells, Development, 138, 1445, 10.1242/dev.065904 · DOI
- Kondo, 2017, Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells, Diabetologia, 60, 1454, 10.1007/s00125-017-4302-7 · DOI
- Yung, 2019, Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals, Nat Commun, 10, 4647, 10.1038/s41467-019-12624-5 · DOI
- Rezania, 2011, Production of functional glucagon-secreting alpha-cells from human embryonic stem cells, Diabetes, 60, 239, 10.2337/db10-0573 · DOI · Paper page
- Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Rep, 4, 591, 10.1016/j.stemcr.2015.02.017 · DOI · Paper page
- Shim, 2007, Directed differentiation of human embryonic stem cells towards a pancreatic cell fate, Diabetologia, 50, 1228, 10.1007/s00125-007-0634-z · DOI · Paper page
- Rezania, 2012, Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice, Diabetes, 61, 2016, 10.2337/db11-1711 · DOI · Paper page
- Schulz, 2012, A scalable system for production of functional pancreatic progenitors from human embryonic stem cells, PLoS One, 7, e37004, 10.1371/journal.pone.0037004 · DOI · Paper page
- Jiang, 2007, Generation of insulin-producing islet-like clusters from human embryonic stem cells, Stem Cells, 25, 1940, 10.1634/stemcells.2006-0761 · DOI · Paper page
- Kroon, 2008, Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo, Nat Biotechnol, 26, 443, 10.1038/nbt1393 · DOI · Paper page
- Bruin, 2015, Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs, Stem Cell Rep, 4, 605, 10.1016/j.stemcr.2015.02.011 · DOI
- Henry, 2018, Initial clinical evaluation of VC-01TM combination product—a stem cell–derived islet replacement for type 1 diabetes (T1D), Diabetes, 67
- Shapiro, 2021, Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device, Cell Rep Med, 2, 100466, 10.1016/j.xcrm.2021.100466 · DOI · Paper page
- Keymeulen, 2021, Stem cell–derived islet replacement therapy (VC-02) demonstrates production of C-peptide in patients with type 1 diabetes (T1D) and hypoglycemia unawareness, Transplantation, 70
- Memon, 2020, Stem cell therapy for diabetes: beta cells versus pancreatic progenitors, Cells, 9, 283, 10.3390/cells9020283 · DOI
- Wallner, 2018, Stem cells and beta cell replacement therapy: a prospective health technology assessment study, BMC Endocr Disord, 18, 6, 10.1186/s12902-018-0233-7 · DOI · Paper page
- Borys, 2021, Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors, Stem Cell Res Ther, 12, 55, 10.1186/s13287-020-02109-4 · DOI
- Komatsu, 2017, Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival, PLoS One, 12, 10.1371/journal.pone.0183780 · DOI
- Bruin, 2013, Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice, Diabetologia, 56, 1987, 10.1007/s00125-013-2955-4 · DOI · Paper page
- Motte, 2014, Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts, Am J Physiol Endocrinol Metab, 307, E838, 10.1152/ajpendo.00219.2014 · DOI · Paper page
- Robert, 2019, Cell mass increase associated with formation of glucose-controlling β-cell mass in device-encapsulated implants of hiPS-derived pancreatic endoderm, Stem Cells Transl Med., 8, 1296, 10.1002/sctm.19-0043 · DOI
- Bruin, 2016, Hypothyroidism impairs human stem cell-derived pancreatic progenitor cell maturation in mice, Diabetes, 65, 1297, 10.2337/db15-1439 · DOI
- Bruin, 2015, Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodeficient rats relative to mice, Stem Cell Rep, 5, 1081, 10.1016/j.stemcr.2015.10.013 · DOI
- Saber, 2018, Sex differences in maturation of human embryonic stem cell-derived β cells in mice, Endocrinology, 159, 1827, 10.1210/en.2018-00048 · DOI
- Mochida, 2020, Insulin-deficient diabetic condition upregulates the insulin-secreting capacity of human induced pluripotent stem cell–derived pancreatic endocrine progenitor cells after implantation in mice, Diabetes, 69, 634, 10.2337/db19-0728 · DOI
- Legøy, 2020, In vivo hyperglycaemia exposure elicits distinct period-dependent effects on human pancreatic progenitor differentiation, conveyed by oxidative stress, Acta Physiol, 228, e13433, 10.1111/apha.13433 · DOI
- Aguayo-Mazzucato, 2013, Thyroid hormone promotes postnatal rat pancreatic beta-cell development and glucose-responsive insulin secretion through MAFA, Diabetes, 62, 1569, 10.2337/db12-0849 · DOI
- Biondi, 2019, Thyroid dysfunction and diabetes mellitus: two closely associated disorders, Endocr Rev, 40, 789, 10.1210/er.2018-00163 · DOI · Paper page
- King, 2007, Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation, Diabetes, 56, 2312, 10.2337/db07-0191 · DOI
- Pipeleers, 1982, Glucose-induced insulin release depends on functional cooperation between islet cells, Proc Natl Acad Sci U S A, 79, 7322, 10.1073/pnas.79.23.7322 · DOI · Paper page
- Holz, 1993, Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37), Nature, 361, 362, 10.1038/361362a0 · DOI · Paper page
- Capozzi, 2019, β Cell tone is defined by proglucagon peptides through cAMP signaling, JCI Insight, 4, e126742, 10.1172/jci.insight.126742 · DOI · Paper page
- Traub, 2017, Pancreatic α cell-derived glucagon-related peptides are required for β cell adaptation and glucose homeostasis, Cell Rep, 18, 3192, 10.1016/j.celrep.2017.03.005 · DOI
- Svendsen, 2018, Insulin secretion depends on intra-islet glucagon signaling, Cell Rep, 25, 1127, 10.1016/j.celrep.2018.10.018 · DOI · Paper page
- Zhu, 2019, Intra-islet glucagon signaling is critical for maintaining glucose homeostasis, JCI Insight, 5, e127994, 10.1172/jci.insight.127994 · DOI · Paper page
- Takeuchi, 2014, Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture, Sci Rep, 4, 4488, 10.1038/srep04488 · DOI
- Guaiquil, 2001, Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells, J Biol Chem, 276, 40955, 10.1074/jbc.M106878200 · DOI
- Russ, 2015, Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro, EMBO J, 34, 1759, 10.15252/embj.201591058 · DOI · Paper page
- Liu, 2021, Chemical combinations potentiate human pluripotent stem cell-derived 3D pancreatic progenitor clusters toward functional beta cells, Nat Commun, 12, 3330, 10.1038/s41467-021-23525-x · DOI
- Millman, 2016, Generation of stem cell-derived β-cells from patients with type 1 diabetes, Nat Commun, 159, 428
- Sharon, 2019, A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets, Cell, 176, 790, 10.1016/j.cell.2018.12.003 · DOI
- van der Meulen, 2015, Role of transcription factors in the transdifferentiation of pancreatic islet cells, J Mol Endocrinol, 54, R103, 10.1530/JME-14-0290 · DOI
- van der Meulen, 2012, Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells, PLoS One, 7, e52181, 10.1371/journal.pone.0052181 · DOI
- Sharon, 2019, Wnt signaling separates the progenitor and endocrine compartments during pancreas development, Cell Rep, 27, 2281, 10.1016/j.celrep.2019.04.083 · DOI
- Hannan, 2013, Generation of multipotent foregut stem cells from human pluripotent stem cells, Stem Cell Rep, 1, 293, 10.1016/j.stemcr.2013.09.003 · DOI
- Trott, 2017, Long-term culture of self-renewing pancreatic progenitors derived from human pluripotent stem cells, Stem Cell Rep, 8, 1675, 10.1016/j.stemcr.2017.05.019 · DOI · Paper page
- Gonçalves, 2021, A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion, Nat Commun, 12, 3144, 10.1038/s41467-021-23295-6 · DOI
- Ma, 2022, Human expandable pancreatic progenitor-derived beta cells ameliorate diabetes, Sci Adv, 8, eabk1826, 10.1126/sciadv.abk1826 · DOI · Paper page
- Sneddon, 2012, Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme, Nature, 491, 765, 10.1038/nature11463 · DOI
- Ameri, 2017, Efficient generation of glucose-responsive beta cells from isolated GP2+ human pancreatic progenitors, Cell Rep., 19, 36, 10.1016/j.celrep.2017.03.032 · DOI
- Kelly, 2011, Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells, Nat Biotechnol, 29, 750, 10.1038/nbt.1931 · DOI · Paper page
- Cogger, 2017, Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors, Nat Commun, 8, 331, 10.1038/s41467-017-00561-0 · DOI · Paper page
- Mahaddalkar, 2020, Generation of pancreatic beta cells from CD177(+) anterior definitive endoderm, Nat Biotechnol, 38, 1061, 10.1038/s41587-020-0492-5 · DOI · Paper page
- Rosado-Olivieri, 2019, YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing β cells, Nat Commun, 10, 1464, 10.1038/s41467-019-09404-6 · DOI
- Davis, 2020, Glucose response by stem cell-derived β cells in vitro is inhibited by a bottleneck in glycolysis, Cell Rep, 31, 107623, 10.1016/j.celrep.2020.107623 · DOI
- Alvarez-Dominguez, 2020, Circadian entrainment triggers maturation of human in vitro islets, Cell Stem Cell, 26, 108, 10.1016/j.stem.2019.11.011 · DOI · Paper page
- Gage, 2013, Initial cell seeding density influences pancreatic endocrine development during in vitro differentiation of human embryonic stem cells, PLoS One, 8, e82076, 10.1371/journal.pone.0082076 · DOI
- Toyoda, 2015, Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells, Stem Cell Res, 14, 185, 10.1016/j.scr.2015.01.007 · DOI
- Toyoda, 2017, Rho-associated kinases and non-muscle myosin IIs inhibit the differentiation of human iPSCs to pancreatic endoderm, Stem Cell Rep, 9, 419, 10.1016/j.stemcr.2017.07.005 · DOI
- Ghazizadeh, 2017, ROCKII inhibition promotes the maturation of human pancreatic beta-like cells, Nat Commun, 8, 298, 10.1038/s41467-017-00129-y · DOI
- Hogrebe, 2020, Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells, Nat Biotechnol, 38, 460, 10.1038/s41587-020-0430-6 · DOI · Paper page
- Lo, 2009, Ethical issues in stem cell research, Endocr Rev, 30, 204, 10.1210/er.2008-0031 · DOI · Paper page
- Thatava, 2013, Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells, Mol Ther, 21, 228, 10.1038/mt.2012.245 · DOI
- Millman, 2017, Autologous pluripotent stem cell-derived β-like cells for diabetes cellular therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
- Zhang, 2006, Sirolimus is associated with reduced islet engraftment and impaired β-cell function, Diabetes, 55, 2429, 10.2337/db06-0173 · DOI · Paper page
- Zahr, 2008, Rapamycin impairs beta-cell proliferation in vivo, Transplant Proc, 40, 436, 10.1016/j.transproceed.2008.02.011 · DOI
- Fraenkel, 2008, mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes, Diabetes, 57, 945, 10.2337/db07-0922 · DOI · Paper page
- Johnson, 2009, Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets, Cell Transplant, 18, 833, 10.3727/096368909X471198 · DOI
200 of 317 shown
Cited by
Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00409-y · Cited by 23
Metadata
- Authors
- Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2022-09-16
- Volume
- 44
- Issue
- 2
- Pages
- 222-253
- ISSN
- 0163-769X
- 1945-7189
- Cited by
- 34
- References
- 58
- Language
- en
- Funders
- Canadian Institutes of Health Research
- Stem Cell Network
- Genome BC
- JDRF
- Vancouver Coastal Health
- Manpei-Suzuki Diabetes foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets. https://app.cochat.ai/papers/10.1210/endrev/bnac021
- The paper
- Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J. (2023). A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets. Endocrine Reviews. https://doi.org/10.1210/endrev/bnac021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.